|
Name |
1,2-Benzenedicarboxylicacid, bis (2-methylpropyl) ester
|
| Molecular Formula | C16H20O4 | |
| IUPAC Name* |
2-O-(2-methylprop-2-enyl)1-O-(2-methylpropyl)benzene-1,2-dicarboxylate
|
|
| SMILES |
C=C(C)COC(=O)c1ccccc1C(=O)OCC(C)C
|
|
| InChI |
InChI=1S/C16H20O4/c1-11(2)9-19-15(17)13-7-5-6-8-14(13)16(18)20-10-12(3)4/h5-8,12H,1,9-10H2,2-4H3
|
|
| InChIKey |
RUGXJKRXAZIUDA-UHFFFAOYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 276.33 | ALogp: | 3.2 |
| HBD: | 0 | HBA: | 4 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 52.6 | Aromatic Rings: | 1 |
| Heavy Atoms: | 20 | QED Weighted: | 0.582 |
| Caco-2 Permeability: | -4.41 | MDCK Permeability: | 0.00003710 |
| Pgp-inhibitor: | 0.036 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.118 |
| 30% Bioavailability (F30%): | 0.943 |
| Blood-Brain-Barrier Penetration (BBB): | 0.101 | Plasma Protein Binding (PPB): | 83.29% |
| Volume Distribution (VD): | 1.405 | Fu: | 10.43% |
| CYP1A2-inhibitor: | 0.814 | CYP1A2-substrate: | 0.127 |
| CYP2C19-inhibitor: | 0.911 | CYP2C19-substrate: | 0.093 |
| CYP2C9-inhibitor: | 0.796 | CYP2C9-substrate: | 0.23 |
| CYP2D6-inhibitor: | 0.041 | CYP2D6-substrate: | 0.114 |
| CYP3A4-inhibitor: | 0.074 | CYP3A4-substrate: | 0.163 |
| Clearance (CL): | 12.855 | Half-life (T1/2): | 0.604 |
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.019 |
| Drug-inuced Liver Injury (DILI): | 0.653 | AMES Toxicity: | 0.027 |
| Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.006 |
| Skin Sensitization: | 0.578 | Carcinogencity: | 0.481 |
| Eye Corrosion: | 0.11 | Eye Irritation: | 0.985 |
| Respiratory Toxicity: | 0.068 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000155 | ![]() |
0.714 | D0S5CU | ![]() |
0.372 | ||
| ENC005690 | ![]() |
0.714 | D0GY5Z | ![]() |
0.348 | ||
| ENC000586 | ![]() |
0.703 | D05KON | ![]() |
0.329 | ||
| ENC001801 | ![]() |
0.592 | D05OFX | ![]() |
0.316 | ||
| ENC003076 | ![]() |
0.589 | D08GJO | ![]() |
0.297 | ||
| ENC000154 | ![]() |
0.581 | D0FN7J | ![]() |
0.295 | ||
| ENC001802 | ![]() |
0.558 | D0G2MH | ![]() |
0.292 | ||
| ENC000300 | ![]() |
0.529 | D06LYG | ![]() |
0.289 | ||
| ENC001804 | ![]() |
0.515 | D0Y0JH | ![]() |
0.289 | ||
| ENC001027 | ![]() |
0.500 | D0RA5Q | ![]() |
0.284 | ||